{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:49:08Z","timestamp":1791748148789,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2023ZD0502400"],"award-info":[{"award-number":["2023ZD0502400"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["PKU2026PKULCXQ030"],"award-info":[{"award-number":["PKU2026PKULCXQ030"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cmi.2026.08.037","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:42:15Z","timestamp":1788478935000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ectopic Epstein\u2013Barr virus infection in T cells identifies reduced therapeutic responsiveness and immune dysfunction after allogeneic haematopoietic stem cell transplantation"],"prefix":"10.1016","author":[{"given":"Zhifan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuojun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilei","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuying","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.08.037_bib1","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","article-title":"Epstein-Barr virus: Biology and clinical disease","volume":"185","author":"Damania","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cmi.2026.08.037_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41409-019-0548-7","article-title":"Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: A comprehensive review from pathogenesis to forthcoming treatment modalities","volume":"55","author":"Al Hamed","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2026.08.037_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11899-013-0162-5","article-title":"Post-transplant lymphoproliferative disease (PTLD): Risk factors, diagnosis, and current treatment strategies","volume":"8","author":"Al-Mansour","year":"2013","journal-title":"Curr Hematologic Malignancy Rep"},{"key":"10.1016\/j.cmi.2026.08.037_bib4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3324\/haematol.2024.286265","article-title":"Letermovir prophylaxis for cytomegalovirus is associated with risk of post-transplant lymphoproliferative disorders after haploidentical stem cell transplantation","volume":"110","author":"Pei","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2026.08.037_bib5","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1182\/blood.2023020075","article-title":"How I treat posttransplant lymphoproliferative disorder","volume":"142","author":"Amengual","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2026.08.037_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1040-8428(02)00119-1","article-title":"Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection","volume":"44","author":"Kasahara","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.cmi.2026.08.037_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1182\/blood.2023021074","article-title":"Chronic active Epstein-Barr virus disease originates from infected hematopoietic stem cells","volume":"143","author":"Wang","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2026.08.037_bib8","first-page":"673","article-title":"EBV-associated T\/NK\u2013cell lymphoproliferative diseases in nonimmunocompromised hosts: Prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood, J Am Soc Hematol"},{"issue":"16_suppl","key":"10.1016\/j.cmi.2026.08.037_bib9","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1200\/JCO.2025.43.16_suppl.7016","article-title":"Worldwide experience of chronic active EBV infection: Retrospective cohort study","volume":"43","author":"Wang","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cmi.2026.08.037_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/bloodadvances.2021005291","article-title":"High risk of relapsed disease in patients with NK\/T-cell chronic active Epstein-Barr virus disease outside of Asia","volume":"6","author":"D\u00e1vila Salda\u00f1a","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.cmi.2026.08.037_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/pbc.22037","article-title":"Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin","volume":"53","author":"Beutel","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cmi.2026.08.037_bib12","first-page":"1219","article-title":"Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan","volume":"144","author":"Su","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cmi.2026.08.037_bib13","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1182\/blood-2015-02-627786","article-title":"Haploidentical vs identical-sibling transplant for AML in remission: A multicenter, prospective study","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2026.08.037_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","article-title":"The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update","volume":"14","author":"Zhang","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.cmi.2026.08.037_bib15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/CM9.0000000000003443","article-title":"Long-term efficacy of CMV\/EBV bivirus-specific T cells for viral co-reactivation after stem cell transplantation","volume":"138","author":"Pei","year":"2025","journal-title":"Chin Med J"},{"key":"10.1016\/j.cmi.2026.08.037_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jinf.2020.11.027","article-title":"Clinical application of Epstein-Barr virus DNA loads in Epstein-Barr virus-associated diseases: A cohort study","volume":"82","author":"Yu","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2026.08.037_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1515\/jtim-2025-0018","article-title":"A novel and safe protocol for patients with severe comorbidity who undergo haploidentical hematopoietic stem cell transplantation: A single-center prospective study","volume":"13","author":"Sun","year":"2025","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.cmi.2026.08.037_bib18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3324\/haematol.2016.144428","article-title":"Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines","volume":"101","author":"Styczynski","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2026.08.037_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatric Blood Cancer"},{"key":"10.1016\/j.cmi.2026.08.037_bib20","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1182\/blood-2010-05-285452","article-title":"Detection of EBV genomes in plasmablasts\/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH","volume":"116","author":"Calattini","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2026.08.037_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1182\/blood.2020005611","article-title":"Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells","volume":"137","author":"Collins","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2026.08.037_bib22","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s41422-020-00402-8","article-title":"Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma","volume":"30","author":"Jin","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.cmi.2026.08.037_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.canlet.2020.02.010","article-title":"Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal carcinoma","volume":"477","author":"Zhao","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cmi.2026.08.037_bib24","doi-asserted-by":"crossref","first-page":"748","DOI":"10.12688\/f1000research.11622.1","article-title":"CyTOF workflow: Differential discovery in high-throughput high-dimensional cytometry datasets","volume":"6","author":"Nowicka","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.cmi.2026.08.037_bib25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","article-title":"Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis","volume":"162","author":"Levine Jacob","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cmi.2026.08.037_bib26","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2016.04.019","article-title":"Mass cytometry: Single cells, many features","volume":"165","author":"Spitzer Matthew","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cmi.2026.08.037_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.567020","article-title":"Management of PTLD after hematopoietic stem cell transplantation: immunological perspectives","volume":"11","author":"Compagno","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2026.08.037_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10875-024-01701-0","article-title":"Single-cell transcriptomic analysis of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"44","author":"Suzuki","year":"2024","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.cmi.2026.08.037_bib29","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2024.037","article-title":"Lymphocytes in patients with chronic active Epstein-Barr virus disease exhibited elevated PD-1\/PD-L1 expression and a prevailing Th2 immune response","volume":"16","author":"Sun","year":"2024","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.037_bib30","doi-asserted-by":"crossref","first-page":"7542","DOI":"10.3390\/jcm11247542","article-title":"Post-transplant lymphoproliferative disease (PTLD) after allogeneic hematopoietic stem cell transplantation: Biology and treatment options","volume":"11","author":"Clerico","year":"2022","journal-title":"J Clin Med"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26004878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26004878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:35:44Z","timestamp":1791747344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26004878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S1198743X26004878"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.08.037","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ectopic Epstein\u2013Barr virus infection in T cells identifies reduced therapeutic responsiveness and immune dysfunction after allogeneic haematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.08.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}